相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab
U. Kopylov et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease
Andreas Tromm et al.
GASTROENTEROLOGY (2011)
Clinical Usefulness of Therapeutic Drug Monitoring of Thiopurines in Patients with Inadequately Controlled Inflammatory Bowel Disease
Melissa L. Haines et al.
INFLAMMATORY BOWEL DISEASES (2011)
A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient
Sharmeel K. Wasan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case-Control Study
Richard G. Armstrong et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
Millie D. Long et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Filip Baert et al.
GASTROENTEROLOGY (2010)
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial
Walter Reinisch et al.
GUT (2010)
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy
Harry Sokol et al.
GUT (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
Gert Van Assche et al.
JOURNAL OF CROHNS & COLITIS (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
Gert Van Assche et al.
JOURNAL OF CROHNS & COLITIS (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease
U. Hindorf et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab
C. Ma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
M. Allez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease: Results From the CHARM Trial
Jean-Frederic Colombel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
Xavier Treton et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Risk of Lymphoma Associated With Combination Anti-Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
Corey A. Siegel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
Konstantinos Karmiris et al.
GASTROENTEROLOGY (2009)
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
H. Fidder et al.
GUT (2009)
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
F. Schnitzler et al.
GUT (2009)
Adalimumab for the treatment of fistulas in patients with Crohn's disease
J-F Colombel et al.
GUT (2009)
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease
J. Rimola et al.
GUT (2009)
Corticosteroids but not Infliximab Increase Short-term Postoperative Infectious Complications in Patients with Ulcerative Colitis
M. Ferrante et al.
INFLAMMATORY BOWEL DISEASES (2009)
Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2009)
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
J. F. Rahier et al.
JOURNAL OF CROHNS & COLITIS (2009)
Immunosuppression-associated lymphoma in IBD
Geert D'Haens et al.
LANCET (2009)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Preoperative Steroid Use and Risk of Postoperative Complications in Patients With Inflammatory Bowel Disease Undergoing Abdominal Surgery
Venkataraman Subramanian et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Can calprotectin predict relapse risk in inflammatory bowel disease?
Renata D'Inca et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: Meta-analysis of placebo-controlled trials
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease
R. Berni Canani et al.
DIGESTIVE AND LIVER DISEASE (2008)
A Randomized Trial of Methotrexate in Combination With Infliximab for the Treatment of Crohn's Disease
Brian Feagan et al.
GASTROENTEROLOGY (2008)
Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: A controlled randomized trial
Geert R. D'Haens et al.
GASTROENTEROLOGY (2008)
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a Randomized trial
Gert Van Assche et al.
GASTROENTEROLOGY (2008)
Risk factors for opportunistic infections in patients with inflammatory bowel disease
Murat Toruner et al.
GASTROENTEROLOGY (2008)
Hepatosplenic T cell lymphoma in inflammatory bowel disease
Matthew Shale et al.
GUT (2008)
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial
Geert D'Haens et al.
LANCET (2008)
Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis
N. Viget et al.
GUT (2008)
Mycophenolate mofetil therapy for refractory inflammatory bowel disease
S. Palaniappan et al.
INFLAMMATORY BOWEL DISEASES (2007)
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine
G. Vernier-Massouille et al.
GUT (2007)
Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes
E. Esrailian et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: A cautionary tale?
Joel R. Rosh et al.
INFLAMMATORY BOWEL DISEASES (2007)
Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
Kathrine Frey Froslie et al.
GASTROENTEROLOGY (2007)
Certolizumab pegol for the treatment of Crohn's disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Thiopurine-induced liver injury in patients with inflammatory bowel disease:: A systematic review
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
American Gastroenterological Association Consensus Development Conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006
M. Clark et al.
GASTROENTEROLOGY (2007)
Adalimumab induction therapy for Crohn disease previously treated with infliximab - A randomized trial
William J. Sandborn et al.
ANNALS OF INTERNAL MEDICINE (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease
Elana A. Maser et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
A simple biological score for predicting low risk of short-term relapse in Crohn's disease
Yann Consigny et al.
INFLAMMATORY BOWEL DISEASES (2006)
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry
GR Lichtenstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Predictors of Crohn's disease
L Beaugerie et al.
GASTROENTEROLOGY (2006)
American Gastroenterological Association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease
GR Lichtenstein et al.
GASTROENTEROLOGY (2006)
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease
CA Solem et al.
INFLAMMATORY BOWEL DISEASES (2005)
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
A Kandiel et al.
GUT (2005)
A randomized, douuble-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine
M Lémann et al.
GASTROENTEROLOGY (2005)
Therapy Insight: osteoporosis in inflammatory bowel disease - advances and retreats
CN Bernstein et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
Small intestine contrast ultrasonography - An alternative to radiology in the assessment of small bowel disease
N Pallotta et al.
INFLAMMATORY BOWEL DISEASES (2005)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
M Daperno et al.
GASTROINTESTINAL ENDOSCOPY (2004)
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial
SB Hanauer et al.
GASTROENTEROLOGY (2004)
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease
S Ardizzone et al.
GASTROENTEROLOGY (2004)
Azathioprine, 6-Mercaptopurine in Inflammatory Bowel Disease: Pharmacology, Efficacy, and Safety
Marla C. Dubinsky
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease
S Wright et al.
GUT (2004)
6-thioguanine can cause serious liver injury in inflammatory bowel disease patients
MC Dubinsky et al.
GASTROENTEROLOGY (2003)
AGA technical review on osteoporosis in gastrointestinal diseases
CN Bernstein et al.
GASTROENTEROLOGY (2003)
Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn's disease
PDP Lundin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine
BA Kaskas et al.
GUT (2003)
Long-term evolution of disease behavior of Crohn's disease
J Cosnes et al.
INFLAMMATORY BOWEL DISEASES (2002)
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
J Markowitz et al.
GASTROENTEROLOGY (2000)
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
JF Colombel et al.
GASTROENTEROLOGY (2000)
Risk factors for surgery and postoperative recurrence in Crohn's disease
O Bernell et al.
ANNALS OF SURGERY (2000)
分享论文
